| Harm reduction principles for healthcare settings M Hawk, RWS Coulter, JE Egan, S Fisk, M Reuel Friedman, M Tula, ... Harm reduction journal 14, 1-9, 2017 | 297 | 2017 |
| Resilience as a research framework and as a cornerstone of prevention research for gay and bisexual men: Theory and evidence AL Herrick, R Stall, H Goldhammer, JE Egan, KH Mayer AIDS and Behavior 18, 1-9, 2014 | 248 | 2014 |
| Factors affecting willingness to provide buprenorphine treatment J Netherland, M Botsko, JE Egan, AJ Saxon, CO Cunningham, ... Journal of substance abuse treatment 36 (3), 244-251, 2009 | 188 | 2009 |
| Migration, neighborhoods, and networks: approaches to understanding how urban environmental conditions affect syndemic adverse health outcomes among gay, bisexual and other men … JE Egan, V Frye, SP Kurtz, C Latkin, M Chen, K Tobin, C Yang, BA Koblin AIDS and Behavior 15, 35-50, 2011 | 163 | 2011 |
| Associations of lesbian, gay, bisexual, transgender, and questioning–inclusive sex education with mental health outcomes and school-based victimization in US high school students CN Proulx, RWS Coulter, JE Egan, DD Matthews, C Mair Journal of Adolescent Health 64 (5), 608-614, 2019 | 125 | 2019 |
| Seasons of risk: anticipated behavior on vacation and interest in episodic antiretroviral pre-exposure prophylaxis (PrEP) among a large national sample of US men who have sex … SA Elsesser, CE Oldenburg, KB Biello, MJ Mimiaga, SA Safren, JE Egan, ... AIDS and Behavior 20, 1400-1407, 2016 | 108 | 2016 |
| Drug treatment outcomes among HIV-infected opioid dependent patients receiving buprenorphine/naloxone DA Fiellin, L Weiss, M Botsko, JE Egan, FL Altice, LB Bazerman, ... Journal of acquired immune deficiency syndromes (1999) 56 (0 1), 2011 | 107 | 2011 |
| Sexual orientation-and race-based discrimination and sexual HIV risk behavior among urban MSM V Frye, V Nandi, J Egan, M Cerda, E Greene, H Van Tieu, DC Ompad, ... AIDS and Behavior 19, 257-269, 2015 | 98 | 2015 |
| School climate & sexual and gender minority adolescent mental health S Colvin, JE Egan, RWS Coulter Journal of youth and adolescence 48, 1938-1951, 2019 | 93 | 2019 |
| Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings PJ Lum, S Little, M Botsko, D Hersh, RE Thawley, JE Egan, J Mitty, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S91-S97, 2011 | 85 | 2011 |
| Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and … I McGowan, CS Dezzutti, A Siegel, J Engstrom, A Nikiforov, K Duffill, ... The Lancet HIV 3 (12), e569-e578, 2016 | 82 | 2016 |
| Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative L Weiss, J Netherland, JE Egan, TP Flanigan, DA Fiellin, R Finkelstein, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S68-S75, 2011 | 81 | 2011 |
| The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment JE Egan, P Casadonte, T Gartenmann, J Martin, EF McCance-Katz, ... Journal of general internal medicine 25, 936-941, 2010 | 77 | 2010 |
| Mental health, drug, and violence interventions for sexual/gender minorities: A systematic review RWS Coulter, JE Egan, S Kinsky, MR Friedman, KL Eckstrand, ... Pediatrics 144 (3), 2019 | 75 | 2019 |
| Improved quality of life for opioid dependent patients receiving buprenorphine treatment in HIV clinics PT Korthuis, MJ Tozzi, V Nandi, DA Fiellin, L Weiss, JE Egan, M Botsko, ... Journal of acquired immune deficiency syndromes (1999) 56 (Suppl 1), S39, 2011 | 72 | 2011 |
| Raising sexual minority youths’ health levels by incorporating resiliencies into health promotion efforts AL Herrick, JE Egan, RWS Coulter, MR Friedman, R Stall American Journal of Public Health 104 (2), 206-210, 2014 | 64 | 2014 |
| Pathways towards risk: syndemic conditions mediate the effect of adversity on HIV risk behaviors among young men who have sex with men (YMSM) A Herrick, R Stall, J Egan, S Schrager, M Kipke Journal of Urban Health 91, 969-982, 2014 | 58 | 2014 |
| Effects of naloxone distribution to likely bystanders: results of an agent-based model C Keane, JE Egan, M Hawk International Journal of Drug Policy 55, 61-69, 2018 | 54 | 2018 |
| The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment L Weiss, JE Egan, M Botsko, J Netherland, DA Fiellin, R Finkelstein JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S7-S13, 2011 | 48 | 2011 |
| The continuing development of health disparities research on lesbian, gay, bisexual, and transgender individuals R Stall, DD Matthews, MR Friedman, S Kinsky, JE Egan, RWS Coulter, ... American Journal of Public Health 106 (5), 787-789, 2016 | 43 | 2016 |
